The World Molecular Imaging Society, American College of Radiology, Society of Nuclear Medicine and Molecular Imaging and members of the National Oncologic PET Registry (NOPR) Working Group issued a statement Friday, June 8, urging CMS to reconsider its decision to decline coverage for PET imaging with sodium fluoride (NaF) for Medicare patients with metastatic cancer.